Dergiler / New Trends in Medicine Sciences / 2023 / Cilt: 4 Sayı: 3

Endothelin-1 Gene Polymorphism in Chronic Obstructive Pulmonary Disease: A Case-Control Study

Sayfa
143–148
Yayın Tarihi
2023-09-21
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Endothelin-1 gene polymorphism may be considered as a predictive genetic factor of COPD in Türkiye.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Abstract Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a common multifactorial disease which has heterogeneous pathogenesis.
📊
Temel Bulgular & Veri:In addition to many pathogenic mechanisms taking part in inflammatory process, Our study group does research on the relation of COPD with single nucleotide gene polymorphism at ET-1 gene.
💡
Sonuç & Katkı:Endothelin-1 gene polymorphism may be considered as a predictive genetic factor of COPD in Türkiye.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Endothelin-1 · Chronic Obstructive Pulmonary Disease · Gene Polymorphism

Abstract

Abstract Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a common multifactorial disease which has heterogeneous pathogenesis. The most important risk factor is smoking. In addition to many pathogenic mechanisms taking part in inflammatory process, Our study group does research on the relation of COPD with single nucleotide gene polymorphism at ET-1 gene. In the current studies there being a high ratio of Endotelin-1 (ET-1) in BAL liquid of COPD cases made researchers think ET-1 may have an important role in pathogenesis of COPD. Methods: This prospective case-control study included 89 patients admitted with COPD and 87 control patients. In our study, we search for the density of single nucleotide gene polymorphism (+134 insA/delA) in ET-1 gene in the 87 smoking COPD and 89 healthy cases. Allele ratio and genotype distribution, distribution amongst three genotype in the COPD patient and healthy control group was analyzed. In this study, for endothelin gene -3A/-4A (-138 insertion/deletion) polymorphism analysis, PCR-RFLP method was used. Results: In comparison with the healthy group, the COPD group has higher ratio of ET-1 gene (+134 insA/delA) polymorphism (p< 0,001). Conclusion: Endotelin-1 gene polymorphism (+134 insA/delA) significantly increased in the patients than healthy ones (p<0,013). Endothelin-1 gene polymorphism may be considered as a predictive genetic factor of COPD in Türkiye.

🔖

Bu Makaleye Atıf Yap

DÜGER, M., KARAKURT, G., SEYHAN, E., BOLATKALE, M. (2023). Endothelin-1 Gene Polymorphism in Chronic Obstructive Pulmonary Disease: A Case-Control Study. New Trends in Medicine Sciences, Cilt: 4 Sayı: 3, 143–148. https://ajindex.com/articles/962287

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585-96
  2. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I; NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022; 10(5):447-58
  3. Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015; 5(2):020415
  4. Lange P, Celli B, Agustí A, et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med. 2015; 373(2):111-22
  5. Burney P, Jarvis D, Perez-Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis. 2015; 19:10-20
  6. Wu X, Yuan B, López E, Bai C, Wang X. Gene polymorphisms and chronic obstructive pulmonary disease. J Cell Mol Med. 2014; 18(1):15-26
  7. He XF, Wei W, Li JL, et al. Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies. Gene. 2013; 523(1):10-19
  8. Hingenboam T. Pulmonary hypertension and chronic obstructive pulmonary Disease. A Case for Treatment. Proc Am Thorac Soc. 2005; 2:12-19
  9. Kaparianos A, Argyropoulou E, Efremidis G, Flordellis C, Spiropoulos K. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study. Eur Rev Med Pharmacol Sci. 2010;14(8):705-19
  10. Spiropoulos K, Trakada G, Nikolaou E, et al. Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma. Respir Med. 2003;97(8): 983-89
  11. Bacakoglu F, Atasever A, Ozhana MH, Gurgun C, Ozkilic H, Guzelant A. Plasma and bronchoalveolar lavage fluid levels of endothelin-1 in patients with Chronic Obstructive Pulmonary Disease and pulmonary hypertension. Respiration. 2003; 70:594-49
  12. Sampsonas F, Antonacopoulou A, Spathas D, et al. Positive association between two polymorphic sites (+134 insA/delA and G198T) of the endothelin-1 gene and chronic obstructivepulmonary disease. A case-control study. Respir Med. 2010; 104(1):114-20
  13. Battistini B, Dussault P. Biosynthesis, distribution and metabolism of endothelins in the pulmonary system. Pulm Phar